Canopy-N: Neoadjuvant Canakinumab And Pembrolizumab In Patients With Surgically Resectable Non-Small Cell Lung Cancer

J. Lee,M. Tsuboi,P. Garrido,E. S. Kim,T. Dong, C. Blin, V. Rodrik-Outmezguine,B. Mookerjee, V. Passos,T. Mok

Journal of Thoracic Oncology(2021)

引用 0|浏览5
暂无评分
关键词
IL-1 beta, canakinumab, pembrolizumab, NSCLC, neoadjuvant, surgery, major pathological response
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要